These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30788385)

  • 41. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
    Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
    J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic Characterization of Male
    Tomczewski MV; Chan JZ; Campbell ZE; Strathdee D; Duncan RE
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining functional classes of Barth syndrome mutation in humans.
    Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM
    Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth syndrome.
    Malhotra A; Kahlon P; Donoho T; Doyle IC
    Recent Pat Biotechnol; 2014; 8(2):136-43. PubMed ID: 25185984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Barth syndrome mutations that cause tafazzin complex lability.
    Claypool SM; Whited K; Srijumnong S; Han X; Koehler CM
    J Cell Biol; 2011 Feb; 192(3):447-62. PubMed ID: 21300850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics.
    Chan JZ; Fernandes MF; Steckel KE; Bradley RM; Hashemi A; Groh MR; Sciaini G; Stark KD; Duncan RE
    Sci Rep; 2022 Jun; 12(1):9466. PubMed ID: 35676289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.
    Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D
    J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes.
    Zegallai HM; Abu-El-Rub E; Olayinka-Adefemi F; Cole LK; Sparagna GC; Marshall AJ; Hatch GM
    FASEB J; 2022 Aug; 36(8):e22443. PubMed ID: 35816277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
    Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
    Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion.
    Tomczewski MV; Chan JZ; Al-Majmaie DM; Liu MR; Cocco AD; Stark KD; Strathdee D; Duncan RE
    Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eponym: Barth syndrome.
    Takeda A; Sudo A; Yamada M; Yamazawa H; Izumi G; Nishino I; Ariga T
    Eur J Pediatr; 2011 Nov; 170(11):1365-7. PubMed ID: 21947198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report: A Chinese child with Barth syndrome caused by a novel
    Che M; Li F; Jia Y; Liu Q; Hu J; Zhang J; Liu S
    Front Cardiovasc Med; 2024; 11():1465912. PubMed ID: 39309604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal case report of Barth syndrome caused by novel
    Zhao X; Li X; Sun W; Jia JA; Yu M; Tian R
    Front Pediatr; 2022; 10():1004485. PubMed ID: 36440345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome.
    Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro Brás LE; Funai K
    J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.
    Wang G; McCain ML; Yang L; He A; Pasqualini FS; Agarwal A; Yuan H; Jiang D; Zhang D; Zangi L; Geva J; Roberts AE; Ma Q; Ding J; Chen J; Wang DZ; Li K; Wang J; Wanders RJ; Kulik W; Vaz FM; Laflamme MA; Murry CE; Chien KR; Kelley RI; Church GM; Parker KK; Pu WT
    Nat Med; 2014 Jun; 20(6):616-23. PubMed ID: 24813252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
    Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A
    Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune function.
    Zegallai HM; Abu-El-Rub E; Olayinka-Adefemi F; Cole LK; Sparagna GC; Marshall AJ; Hatch GM
    bioRxiv; 2021 Sep; ():. PubMed ID: 34729562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome.
    Zapała B; Płatek T; Wybrańska I
    Ann Hum Genet; 2015 May; 79(3):218-24. PubMed ID: 25776009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome.
    Chowdhury A; Boshnakovska A; Aich A; Methi A; Vergel Leon AM; Silbern I; Lüchtenborg C; Cyganek L; Prochazka J; Sedlacek R; Lindovsky J; Wachs D; Nichtova Z; Zudova D; Koubkova G; Fischer A; Urlaub H; Brügger B; Katschinski DM; Dudek J; Rehling P
    EMBO Mol Med; 2023 Sep; 15(9):e17399. PubMed ID: 37533404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
    Bowron A; Frost R; Powers VE; Thomas PH; Heales SJ; Steward CG
    J Inherit Metab Dis; 2013 Sep; 36(5):741-6. PubMed ID: 23109063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.